DNA AMPLIFICATION IN EXPERIMENTAL PNEUMOCYSTOSIS - CHARACTERIZATION OF SERUM PNEUMOCYSTIS-CARINII DNA AND POTENTIAL PNEUMOCYSTIS-CARINII CARRIER STATES
K. Sepkowitz et al., DNA AMPLIFICATION IN EXPERIMENTAL PNEUMOCYSTOSIS - CHARACTERIZATION OF SERUM PNEUMOCYSTIS-CARINII DNA AND POTENTIAL PNEUMOCYSTIS-CARINII CARRIER STATES, The Journal of infectious diseases, 168(2), 1993, pp. 421-426
DNA amplification has identified P. carinii DNA in diverse biologic sp
ecimens, including the serum of patients with P. carinii pneumonia. To
further examine the relationship between P. carinii DNA in serum and
P. carinii infection, the corticosteroid-treated rat model of pneumocy
stosis was studied. By 4 weeks of immunosuppression, P. carinii DNA wa
s detected in rat lungs and by 6 weeks, in their serum. P. carinii DNA
persisted in lung tissue as long as 5 months after the withdrawal of
steroids. Serum DNA disappeared 2 weeks after steroids were withdrawn.
Nonimmunocompromised, sentinel rats housed near immunocompromised, P.
carinii-infected rats also were studied. Within 6 weeks, P. carinii D
NA became detectable in lung and by 8 weeks, in serum. P. carinii DNA
disappeared rapidly from lungs and sera after sentinel rats were isola
ted away from corticosteroid-treated rats. These findings support the
contagious transmission of P. carinii and suggest facile development o
f P. carinii carrier states.